Your session is about to expire
← Back to Search
Amlodipine Arm for High Blood Pressure
Study Summary
This trial is designed to figure out how striatin-mediated salt sensitive blood pressure works in order to better understand how to treat it.
- High Blood Pressure
- Hypertension
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have high blood pressure caused by another health condition.You have a specific genetic variant called rs2540923A or both Striatin rs888083 and rs6744560 risk alleles.You are 18 years old or older.You are taking a maximum of two medications for high blood pressure.Your kidney, metabolism, electrolytes, blood cells, and cholesterol levels are within normal range.If you are taking certain medications for blood pressure, you need to stop taking them for 3 months before participating in the study.You have a heart condition other than high blood pressure.You have kidney, heart, or brain diseases.You have diabetes.You are a smoker.You are taking medications for high blood pressure or thyroid replacement, but no other medications are allowed.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Amlodipine Arm
- Group 2: Epleronone Arm
Frequently Asked Questions
What is the limit for enrolment in this clinical experiment?
"Affirmative, clinicaltrials.gov's data states that this research project is still recruiting volunteers, having been first posted on January 15th 2019 and last modified on November 7th 2022. For successful completion of the study, 250 participants need to be enrolled from one institution."
Have there been precedent investigations involving the Epleronone Arm?
"At the current time, there are 40 active studies of Epleronone Arm in progress with 8 trialing within Phase 3. With most investigations being conducted out of Nagoya, Aichi, a total 336 sites have been identified to trial this drug candidate."
Are there any restrictions on who is eligible to take part in this research?
"To be eligible for inclusion in this clinical trial, applicants must have hypertension and they must fall within the age range of 18 to 70 years. The total number of participants sought is approximately 250 individuals."
Has the FDA given their sanction to Epleronone Arm?
"A score of 3 has been assigned to Epleronone Arm due to the Phase 4 trial status, which signifies that this medication is already cleared for use by regulatory bodies."
Are new participants being admitted to this clinical experiment?
"According to information available on clinicaltrials.gov, this trial is presently searching for participants with its original posting date of January 15th 2019 and most recent update conducted in November 7th 2022."
To what ailments is Epleronone Arm typically recommended as a treatment?
"Epleronone Arm is a frequently used intervention for cardiovascular related events, as well as high-risk conditions such as dyslipidemias and coronary artery disease (CAD)."
Does the age cutoff for eligibility in this trial exceed 40 years?
"This clinical trial is only accepting patients aged between 18 to 70 years old. Patients younger than 18 have access to 56 different trials, and those over 65 can apply for 700 other studies."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger